Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients

Psychological Medicine

Volumn 44, Issue 8, 2014, Pages 1591-1604

  Roiz Santianez R ^a,b,c   Ayesa Arriola, R ^a,b,c   Tordesillas Gutierrez D ^a,b,c   Ortiz Garcia De La Foz V ^a,b,c   Perez Iglesias R ^a,b,c,d   Pazos, A ^a,b,c   Sanchez E ^a   Crespo Facorro, B ^a,b,c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

brain morphology; clinical cognition; cognitive; first episode; follow up studies; Key words Antipsychotics; psychosis; schizophrenia; structural magnetic resonance imaging

Indexed keywords

ADULT; BRAIN; DISEASE COURSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SCHIZOPHRENIA;

ADULT; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA;

EID: 84899741410     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713002365     Document Type: Article

References (76)

1. Andreasen NC (1983). The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa: Iowa City.
2. Andreasen NC (1984). The Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa: Iowa City. Andreasen NC, Flaum M, Arndt S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615-623.
3. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC (2011). Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biological Psychiatry 70, 672-679.
4. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC (2010). Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biological Psychiatry 67, 255-262.
5. Andreasen NC, Rajarethinam R, Cizadlo T, Arndt S, Swayze 2nd VW, Flashman LA, O'Leary DS, Ehrhardt JC, Yuh WT (1996). Automatic atlas-based volume estimation of human brain regions from MR images. Journal of Computer Assisted Tomography 20, 98-106.
6. Ayesa-Arriola R, Perez-Iglesias R, Rodriguez-Sanchez JM, Pardo-Garcia G, Tabares-Seisdedos R, Ayuso-Mateos JL, Vazquez-Barquero JL, Crespo-Facorro B (2013). Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 43, 23-28.
7. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler S, Mayerhoff D, Lieberman JA (1991). Neuropsychological deficits in the early course of first episode schizophrenia. Schizophrenia Research 5, 198-199.
8. Boonstra G, Cahn W, Schnack HG, Hulshoff Pol HE, Minderhoud TC, Kahn RS, van Haren NE (2011). Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change. Schizophrenia Research 132, 84-90.
9. Bozikas VP, Andreou C (2011). Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Australian and New Zealand Journal of Psychiatry 45, 93-108.
10. Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS (2002). Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry 59, 1002-1010.
11. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M (1994). Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry 151, 1430-1436.
12. Crespo-Facorro B, Barbadillo L, Pelayo-Teran JM, Rodriguez-Sanchez JM (2007a). Neuropsychological functioning and brain structure in schizophrenia. International Review of Psychiatry 19, 325-336.
13. Crespo-Facorro B, Perez-Iglesias R, Mata I, Martinez-Garcia O, Ortiz V, Pelayo-Teran JM, Valdizan E, Vazquez-Barquero JL (2012). Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis. Psychopharmacology (Berlin) 219, 225-233.
14. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, Gonzalez-Blanch C, Perez-Iglesias R, Gutierrez A, de Lucas EM, Tordesillas D, Vazquez-Barquero JL (2007b). Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophrenia Research 91, 87-96.
15. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, Rodriguez-Sanchez JM, Perez-Iglesias R, Gonzalez-Blanch C, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Diez C, Magnotta VA, Andreasen NC, Vazquez-Barquero JL (2007c). Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. NeuroImage 35, 1613-1623.
16. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, Pelayo-Teran JM, Rodriguez-Sanchez JM, Tordesillas-Gutierrez D, Ramirez M, Martinez O, Gutierrez A, de Lucas EM, Vazquez-Barquero JL (2008). Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 1936-1943.
17. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, Tordesillas-Gutierrez D, Mata I, Rodriguez-Sanchez JM, de Lucas EM, Vazquez-Barquero JL (2009). Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers. Schizophrenia Research 115, 191-201.
18. Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Gervin M, McTigue O, Kinsella A, Waddington JL, Larkin C, O'Callaghan E (2009). Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. British Journal of Psychiatry 194, 18-24.
19. DeLisi LE (2008). The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophrenia Bulletin 34, 312-321.
20. DeLisi LE, Hoff AL (2005). Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Research 138, 265-268.
21. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R (1997). Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research 74, 129-140.
22. Diamond MC (2001). Response of the brain to enrichment. Annals of the Brazilian Academy of Sciences 73, 221-220.
23. Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Lee CU, McCarley RW, Shenton ME (2004). Follow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophrenia Research 71, 349-351.
24. Falkai P, Malchow B, Wobrock T, Gruber O, Schmitt A, Honer WG, Pajonk FG, Sun F, Cannon TD (2013). The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study. European Archives of Psychiatry and Clinical Neuroscience 263, 469-473.
25. First MB, Spitzer RL, Gibbon M, Williams J (2001). Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Non-Patient Edition. New York State Psychiatric Institute: New York.
26. Gonzalez-Blanch C, Crespo-Facorro B, Alvarez-Jimenez M, Rodriguez-Sanchez JM, Pelayo-Teran JM, Perez-Iglesias R, Vazquez-Barquero JL (2007). Cognitive dimensions in first-episode schizophrenia spectrum disorders. Journal of Psychiatric Research 41, 968-977.
27. Gronenschild EH, Habets P, Jacobs HI, Mengelers R, Rozendaal N, van Os J, Marcelis M (2012). The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements. PLoS One 7, e38234.
28. Grube BS, Bilder RM, Goldman RS (1998). Meta-analysis of symptom factors in schizophrenia. Schizophrenia Research 31, 113-120.
29. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC (1998). A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry 55, 145-152.
30. Haijma SV, van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS (2012). Brain volumes in schizophrenia: a meta-analysis in over 18000 subjects. Schizophrenia Bulletin. Published online: 5 October 2012. doi: 10. 1093/schbul/sbs118.
31. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B (2006). Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 32, 180-194.
32. Harris G, Andreasen NC, Cizadlo T, Bailey JM, Bockholt HJ, Magnotta VA, Arndt S (1999). Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. Journal of Computer Assisted Tomography 23, 144-154.
33. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M (2003). Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry 60, 585-594.
34. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68, 128-137.
35. Hulshoff Pol HE, Hoek HW, Susser E, Brown AS, Dingemans A, Schnack HG, van Haren NE, Pereira Ramos LM, Gispen-de Wied CC, Kahn RS (2000). Prenatal exposure to famine and brain morphology in schizophrenia. American Journal of Psychiatry 157, 1170-1172.
36. Janca A, Kastrup M, Katschnig H, Lopez-Ibor JJ Jr., Mezzich JE, Sartorius N (1996). The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders. Social Psychiatry and Psychiatric Epidemiology 31, 349-354.
37. Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A (2006). Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. NeuroImage 30, 436-443.
38. Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B, Pacheco J, Albert M, Killiany R, Blacker D, Maguire P, Rosas D, Makris N, Gollub R, Dale A, Dickerson BC, Fischl B (2009). MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 46, 177-192.
39. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW (2003). Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. American Journal of Psychiatry 160, 156-164.
40. Kempton MJ, Stahl D, Williams SC, DeLisi LE (2010). Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophrenia Research 120, 54-62.
41. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW (1994). Changes in caudate volume with neuroleptic treatment. Lancet 344, 1434.
42. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW (1998). Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? Journal of Psychiatric Research 32, 161-167.
43. Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, Huber CG, Suarez D, Haro JM, Novick D, Dittmann RW, Schimmelmann BG (2008). Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatrica Scandinavica 118, 220-229.
44. Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R (2001). Longitudinal study of brain morphology in first episode schizophrenia. Biological Psychiatry 49, 487-499.
45. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62, 361-370.
46. Madsen AL, Karle A, Rubin P, Cortsen M, Andersen HS, Hemmingsen R (1999). Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment. Acta Psychiatrica Scandinavica 100, 367-374.
47. Magnotta VA, Andreasen NC, Schultz SK, Harris G, Cizadlo T, Heckel D, Nopoulos P, Flaum M (1999). Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging. Cerebral Cortex 9, 151-160.
48. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D (2002). Structural MR image processing using the BRAINS2 toolbox. Computerized Medical Imaging and Graphics 26, 251-264.
49. Massana G, Salgado-Pineda P, Junque C, Perez M, Baeza I, Pons A, Massana J, Navarro V, Blanch J, Morer A, Mercader JM, Bernardo M (2005). Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. Journal of Clinical Psychopharmacology 25, 111-117.
50. Menezes NM, Arenovich T, Zipursky RB (2006). A systematic review of longitudinal outcome studies of first-episode psychosis. Psychological Medicine 36, 1349-1362.
51. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T, Koo MS, Shenton ME, McCarley RW (2007). Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biological Psychiatry 62, 773-783.
52. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM (2011). Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biological Psychiatry 70, 88-96.
53. Oldfield RC (1971). The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9, 97-113.
54. Overall JE, Gorman DR (1962). The Brief Psychiatric Rating Scale. Psychology Report 10, 799-821.
55. Pajonk FG, Wobrock T, Gruber O, Scherk H, Berner D, Kaizl I, Kierer A, Muller S, Oest M, Meyer T, Backens M, Schneider-Axmann T, Thornton AE, Honer WG, Falkai P (2010). Hippocampal plasticity in response to exercise in schizophrenia. Archives of General Psychiatry 67, 133-143.
56. Pantelis C, Yücel M, Wood SJ, Velakoulis D, Sun D, Berger G, Stuart GW, Yung A, Phillips L, McGorry PD (2005). Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin 31, 672-696.
57. Pelayo-Teran JM, Perez-Iglesias R, Ramirez-Bonilla M, Gonzalez-Blanch C, Martinez-Garcia O, Pardo-Garcia G, Rodriguez-Sanchez JM, Roiz-Santianez R, Tordesillas-Gutierrez D, Mata I, Vazquez-Barquero JL, Crespo-Facorro B (2008). Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Intervention in Psychiatry 2, 178-187.
58. Rais M, Cahn W, van Haren N, Schnack H, Caspers E, Hulshoff Pol H, Kahn R (2008). Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. American Journal of Psychiatry 165, 490-496.
59. Rodriguez-Sanchez JM, Ayesa-Arriola R, Perez-Iglesias R, Perianez JA, Martinez-Garcia O, Gomez-Ruiz E, Tabares-Seisdedos R, Crespo-Facorro B (2013). Course of cognitive deficits in first episode of non-affective psychosis: a 3-year follow-up study. Schizophrenia Research. Published online: 27 July 2013. doi: 10. 1016/j. schres. 2013. 06. 042.
60. Roiz-Santianez R, Perez-Iglesias R, Ortiz-Garcia de la Foz V, Tordesillas-Gutierrez D, Mata I, Gonzalez-Mandly A, Pazos A, Tabares-Seisdedos R, Vazquez-Barquero JL, Crespo-Facorro B (2012). One year longitudinal study of the straight gyrus morphometry in first-episode schizophrenia-spectrum patients. Psychiatry Research 202, 80-83.
61. Schaufelberger MS, Lappin JM, Duran FL, Rosa PG, Uchida RR, Santos LC, Murray RM, McGuire PK, Scazufca M, Menezes PR, Busatto GF (2011). Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychological Medicine 41, 1677-1689.
62. Senjem ML, Gunter JL, Shiung MM, Petersen RC, Jack CR Jr. (2005). Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. NeuroImage 26, 600-608.
63. Smith MJ, Wang L, Cronenwett W, Goldman MB, Mamah D, Barch DM, Csernansky JG (2011). Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. Schizophrenia Research 131, 174-183.
64. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003). Mapping cortical change across the human life span. Nature Neuroscience 6, 309-315.
65. Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn ML, Jellema K, Kahn RS (2000). Structural brain abnormalities in patients with schizophrenia and their healthy siblings. American Journal of Psychiatry 157, 416-421.
66. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA (2006). Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry 188, 510-518.
67. Terribilli D, Schaufelberger MS, Duran FL, Zanetti MV, Curiati PK, Menezes PR, Scazufca M, Amaro R Jr., Leite CC, Busatto GF (2011). Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiology of Aging 32, 354-368.
68. van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS (2008). Schizophrenia as a progressive brain disease. European Psychiatry 23, 245-254.
69. van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS (2012). Confounders of excessive brain volume loss in schizophrenia. Neuroscience and Biobehavioral Reviews. Published online: 20 September 2012. doi: 10. 1016/j. neubiorev. 2012. 09. 006.
70. van Haren NE, Koolschijn PC, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS (2010). Cigarette smoking and progressive brain volume loss in schizophrenia. European Neuropsychopharmacology 20, 454-458.
71. van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS (2011). Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry 68, 871-880.
72. Vita A, De Peri L, Silenzi C, Dieci M (2006). Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophrenia Research 82, 75-88.
73. Walters RJ, Fox NC, Crum WR, Taube D, Thomas DJ (2001). Haemodialysis and cerebral oedema. Nephron 87, 143-147.
74. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157, 16-25.
75. Zipursky RB, Christensen BK, Mikulis DJ (2004). Stable deficits in gray matter volumes following a first episode of schizophrenia. Schizophrenia Research 71, 515-516.
76. Zipursky RB, Reilly TJ, Murray RM (2012). The myth of schizophrenia as a progressive brain disease. Schizophrenia Bulletin. Published online 20 Novmber 2012. doi: 10. 1093/schbul/sbs135.